, Tracking Stock Market Picks
Enter Symbol:
Bioscrip, Inc. (BIOS) [hlAlert]

down 81.21 %

Bioscrip, Inc. (BIOS) rated Buy with price target $7.50 by Feltl & Co.

Posted on: Friday,  Nov 8, 2013  12:25 PM ET by Feltl & Co.

Feltl & Co. rated Buy Bioscrip, Inc. (NASDAQ: BIOS) on 11/08/2013. Previously Feltl & Co. rated Strong Buy Bioscrip, Inc. (NASDAQ: BIOS)
on 04/09/2013., when the stock price was $12.51. Since then, Bioscrip, Inc. has lost 81.22% as of 01/22/2016's recent price of $2.35.
If you would have followed the previous Feltl & Co.'s recommendation on BIOS, you would have lost 81.21% of your investment in 1018 days.

BioScrip, Inc. is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions. The Company has two operating segments: specialty pharmaceutical services (Specialty Services) and pharmacy benefit management (PBM) services. The Company's Specialty Services include the support, dispensing and distribution, patient care management, data reporting, as well as a range of other therapy management services for chronic health conditions. These medications include orals, injectables and infusibles used to treat patients living with chronic health conditions and are provided directly to patients and physicians. Its PBM services include pharmacy network management, claims processing and benefit design, clinical services, drug utilization review, discount prescription card programs and mail order pharmacy fulfillment.

Feltl and Company's Research Department is focused on micro to small market capitalization companies that are not widely covered by other research firms. Our research universe is focused and organized around the sectors of Technology, HealthCare, and Leisure/Consumer. Feltl and Company holds its research department to very high standards, and strives to provide value- added investment ideas through sound fundamental analysis. Feltl and Company's Research Department includes six senior analysts and one associate analyst with many years of investment analysis experience. Although we are focused on, and committed to, companies in the Upper Midwest, our reach extends from coast to coast. About half of the companies we cover are headquartered outside our "backyard." Our analysts have significant industry experience and strive to know their companies inside and out. Through stringent analysis, they provide value by creating a disciplined application of company valuation, allowing our clients to make sound investment decisions.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2013 12:25 PM Buy
6.03 7.50
as of 12/13/2013
1 Week up  1.24 %
1 Month up  13.17 %
3 Months down  -43.90 %
1 YTD up  8.29 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2013 3:25 PM Buy
15.81 20.00
4/9/2013 11:25 AM Buy
12.51 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy